Chiba, Japan

Yuko Yoshida

This inventor holds 1 USPTO granted patent. Top assignee: Ss Pharmaceutical Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuko Yoshida. Retrieved from https://idiyas.com/inventor/yuko-yoshida-1x0wi41j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuko Yoshida: Innovator in Pharmaceutical Chemistry

Introduction

Yuko Yoshida is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Yuko Yoshida holds a patent for an 8-piperazinyl-1,7-naphthyridine derivative that exhibits pharmaceutical activity. This compound, represented by a specific formula, includes various functional groups such as hydrogen atoms, formyl groups, and substituted phenyl groups. The compound has demonstrated excellent anti-inflammatory, antiarrhythmic, and cardiotonic effects, making it a valuable candidate for use as an anti-inflammatory drug and a medicine for circulatory organs.

Career Highlights

Yuko Yoshida is associated with Ss Pharmaceutical Co., Ltd., where she continues to advance her research in pharmaceutical innovations. Her work has been instrumental in developing new therapeutic agents that address critical health issues.

Collaborations

Yuko has collaborated with notable colleagues, including Haruyoshi Honda and Tadayuki Kouda, to further enhance her research efforts and contribute to the scientific community.

Conclusion

Yuko Yoshida's contributions to pharmaceutical chemistry highlight her innovative spirit and dedication to improving healthcare through her inventions. Her work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…